Financials

  • Market Capitalization 232.74 M
  • Employee 122
  • Founded 2020
  • CEO N/A
  • Website www.invivyd.com
  • Headquarter Delaware, United States
  • FIGI BBG00W4ML039
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-8.23
Rapporto prezzo/fatturato
7.96

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3518
FULC
Fulcrum Therapeutics, Inc. - Common Stock
3.54 USD+1.14%-4.84%-1.39%-55.30%235.88 M USD
3521
TARA
Protara Therapeutics, Inc. - Common Stock
4.18 USD-3.24%+2.20%+6.09%+31.45%234.93 M USD
3542
OBIO
Orchestra BioMed Holdings, Inc. - Ordinary Shares
3.82 USD-4.26%-7.28%-7.28%+25.66%228.74 M USD
3547
KPTI
Karyopharm Therapeutics Inc. - Common Stock
10.05 USD-2.80%+4.91%+4.15%+4.25%227.76 M USD

Notizie